RBSFY yields 5.65% · JNJ yields 2.13%● Live data
📍 RBSFY pulled ahead of the other in Year 1
Combined, RBSFY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RBSFY + JNJ for your $10,000?
Rubis, through its subsidiaries, engages in the operation of bulk liquid storage facilities and distribution of petroleum products in Europe, Africa, and the Caribbean. The company operates in two divisions, Retail & Marketing and Support & Services, It operates terminals that provide bulk liquid storage facilities for petroleum products, chemical products, biofuels, fertilizers, molasses, edible oils, and agri-food products; and trades in and distributes fuels, liquefied gases, bitumen, commercial fuel oil, aviation and marine fuel, and lubricants, as well as butane and propane. The company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing business. It serves gas stations, private individuals, industrial professionals, public works, energy distribution professionals, supermarkets, oil companies, chemical and petrochemical companies, agricultural cooperatives traders, etc., as well as services, transportation, hotel, aviation, marine, and other industries The company was founded in 1990 and is headquartered in Paris, France.
Full RBSFY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.